Pharma and biotech companies: Don’t just merge, innovate

By Patrick Skerrett @PJSkerrett

April 20, 2016

APStock

Editor’s note: This article was mistakenly published. It has been removed from the website.

About the Author

Patrick Skerrett

Editor, First Opinion

Patrick Skerrett edits First Opinion, STAT's perspective and opinion section.

patrick.skerrett@statnews.com

Tags

pharmaceutical industry

Leave a Comment Cancel reply

Recommended

A dosage of Spinraza.

Cure ‘futures’ offer a way to pay for million-dollar…

Cure ‘futures’ offer a way to pay for million-dollar medicines

Genetic testing plus IVF can sidestep genetic disease and…

Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies

hiding mistakes

Solving the fake news problem in science

Solving the fake news problem in science

Recommended Stories

A dosage of Spinraza.

First Opinion

Cure ‘futures’ offer a way to pay for million-dollar medicines

By Maria Ferrante-Schepis

IVF

First Opinion

Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies

By Lee D. Cooper

advertisement

hiding mistakes

First Opinion

Solving the fake news problem in science

By Josh Nicholson

Blister packs filled with capsules

First Opinion

How traditional pharmacies can survive the Amazon threat

By Vik Panda

Prescription pill bottles

First Opinion

I’ve been forced to go through ‘step therapy.’ Don’t make Medicare Part B participants do that

By Elizabeth Krempley